Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Adare Pharma Solutions announced it is further investing in its Pessano facility in Milan, Italy, with the addition of a high-shear mixer granulator to complement existing fluid bed capabilities.
read more
Adare Pharma Solutions announced it has strengthened its executive leadership team with two key hires. Robert Muschert has joined Adare as Chief Commercial Officer, and Dr. Vipan Dhall has joined as Chief Scientific Officer.
read more
Wednesday, December 01, 2021
Adare, a technology-driven contract development and manufacturing organization (CDMO), announced today the acquisition of Frontida BioPharm, a vertically integrated CDMO focused on oral formulations.
read more
Adare Pharma Solutions announced it has selected Vantage Solutions to lead a major upgrade of their pharmaceutical packaging capabilities.
read more
Adare Pharma Solutions, a CDMO focused on oral dosage forms, announced that work has begun to add packaging capabilities and further warehousing capacity at its Pessano facility in Milan, Italy.
read more
Adare Pharmaceuticals, a global specialty pharmaceutical company, will present its company overview on Tuesday, June 7, at 1:45 PM, in Room 1, at the 2016 BIO International Convention. Hosted by the Biotechnology Industry Organization (BIO), this ...
read more
Adare and NLS announced a collaboration to develop mazindol CR product candidates for the treatment of narcolepsy and ADHD.
read more
Monday, February 12, 2018
ADC Biotechnology (ADC Bio) is developing a ‘downstream bioconjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing.
read more
Wednesday, April 25, 2018
ADC Biotechnology has secured £1.14 million in funding from investment managers, Downing.
read more
Wednesday, December 06, 2017
ADC Biotechnology announced the signing of a partnership agreement with multi-disciplined engineering specialists, WHP.
read more
Monday, September 25, 2017
ADC Biotechnology announces it has secured investment for the construction of an $11 million bioconjugation facility at its new site in Deeside, North Wales, UK.
read more
Synaffix announced that ADC Therapeutics has triggered a third target-specific license under its existing Commercial License Agreement dated October 2016.
read more
Adcytherix SAS announced its incorporation and seed funding of € 30 million to develop novel antibody-drug- conjugates (ADCs) for the treatment of high unmet need diseases such as cancer.
read more
The Addario Lung Cancer Medical Institute (ALCMI) and Biocept announce a clinical collaboration and initiation of ALCMI-009 liquid biopsy clinical trial.
read more
Adents has addressed a compliance issue through its recently introduced, Blockchain-based Adents NovaTrack product.
read more